India may give SII emergency authorization to Oxford vaccine

Sources within Niti Aayog revealed that the Government is considering granting emergency use approval of the coronavirus vaccine developed by Oxford.

0
COVID-19 Updates
  • World 65,464,328
    World
    Confirmed: 65,464,328
    Active: 18,636,782
    Recovered: 45,317,196
    Death: 1,510,350
  • USA 14,503,229
    USA
    Confirmed: 14,503,229
    Active: 5,683,399
    Recovered: 8,537,425
    Death: 282,405
  • India 9,564,565
    India
    Confirmed: 9,564,565
    Active: 417,216
    Recovered: 9,008,247
    Death: 139,102
  • Brazil 6,487,084
    Brazil
    Confirmed: 6,487,084
    Active: 586,804
    Recovered: 5,725,010
    Death: 175,270
  • Russia 2,375,546
    Russia
    Confirmed: 2,375,546
    Active: 474,088
    Recovered: 1,859,851
    Death: 41,607
  • UK 1,674,134
    UK
    Confirmed: 1,674,134
    Active: 1,614,021
    Recovered: N/A
    Death: 60,113
  • Italy 1,664,829
    Italy
    Confirmed: 1,664,829
    Active: 759,982
    Recovered: 846,809
    Death: 58,038
  • Germany 1,128,730
    Germany
    Confirmed: 1,128,730
    Active: 310,470
    Recovered: 800,000
    Death: 18,260
  • Turkey 733,261
    Turkey
    Confirmed: 733,261
    Active: 300,614
    Recovered: 418,331
    Death: 14,316
  • Pakistan 406,810
    Pakistan
    Confirmed: 406,810
    Active: 51,654
    Recovered: 346,951
    Death: 8,205
  • China 86,567
    China
    Confirmed: 86,567
    Active: 266
    Recovered: 81,667
    Death: 4,634

New Delhi, 22/11: Coronavirus update: India is considering giving the emergency use authorization of Oxford’s coronavirus vaccine to Serum Institute of India(SII), based in Pune. However, the catch is that the authorization will only be approved if AstraZeneca gets the same from the British Government. Vinod Paul, a member of the Niti Aayog, revealed the possibility and also added that if the clinical trials of the vaccine in India go as planned, the Phase-III trials would be completed by February 2021.

 

Get real time updates directly on you device, subscribe now.

Leave A Reply

Your email address will not be published.